Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha - PubMed (original) (raw)
Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha
V A Danis et al. Clin Exp Immunol. 1990 Jun.
Abstract
IL-1 production (secreted and cell-associated) was measured in monocyte cultures stimulated by a variety of agents in vitro. Monocytes either adherent to conventional plastic culture plates in serum-free conditions, or in suspension in culture medium containing serum were stimulated to produce IL-1 during culture. In non-adherent, serum-free conditions, monocytes produced very low or undetectable amounts of IL-1 during 20 h of culture. Lipopolysaccharide (LPS) induced equivalent amounts of secreted and cell-associated IL-1, although at very low concentrations more cell-associated IL-1 was produced. IL-1 production in response to LPS could be augmented by crude lymphokine, IFN-gamma, or tumour necrosis factor (TNF) alpha. TNF-alpha preferentially augmented the production of cell-associated IL-1 in LPS-stimulated cultures. TNF-alpha induced a significant amount of IL-1 (mainly cell-associated) directly but could also induce IL-1 secretion when combined with IL-2 or IFN-gamma, or when in the presence of serum. IL-2 acted synergistically with low concentrations of IFN-gamma or IL-1 to induce significant levels of IL-1 production. IFN-alpha did not induce any IL-1 production, but was a potent inhibitor of IL-1 production induced by a variety of stimuli. These results suggest that IL-1 production may be enhanced or reduced by different cytokines at concentrations likely to be found in chronic inflammatory lesions.
Similar articles
- Monocyte deactivation--rationale for a new therapeutic strategy in sepsis.
Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Müller JM, Döcke WD, Kox WJ. Volk HD, et al. Intensive Care Med. 1996 Oct;22 Suppl 4:S474-81. doi: 10.1007/BF01743727. Intensive Care Med. 1996. PMID: 8923092 Review. - The mediators of inflammation (interleukin 1, interferon-tau, and tumor necrosis factor) and their relevance to rejection.
Halloran PF, Cockfield SM, Madrenas J. Halloran PF, et al. Transplant Proc. 1989 Feb;21(1 Pt 1):26-30. Transplant Proc. 1989. PMID: 2495605 Review. No abstract available.
Cited by
- Decades Long Involvement of THP-1 Cells as a Model for Macrophage Research: A Comprehensive Review.
Sharma P, Venkatachalam K, Binesh A. Sharma P, et al. Antiinflamm Antiallergy Agents Med Chem. 2024;23(2):85-104. doi: 10.2174/0118715230294413240415054610. Antiinflamm Antiallergy Agents Med Chem. 2024. PMID: 38676532 Review. - A Novel Method for the Production of an Autologous Anti-Inflammatory and Anti-Catabolic Product (Cytorich) from Human Blood: A Prospective Treatment for the COVID-19-Induced Cytokine Storm.
Brokhman I, Watkin AMT, Bacher JC, Glazer SA, Galea AM. Brokhman I, et al. Med Sci Monit. 2021 Nov 19;27:e934365. doi: 10.12659/MSM.934365. Med Sci Monit. 2021. PMID: 34795200 Free PMC article. - Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation.
Davis JM 3rd, Crowson CS, Knutson KL, Achenbach SJ, Strausbauch MA, Therneau TM, Matteson EL, Gabriel SE, Wettstein PJ. Davis JM 3rd, et al. Clin Immunol. 2020 Feb;211:108342. doi: 10.1016/j.clim.2020.108342. Epub 2020 Jan 8. Clin Immunol. 2020. PMID: 31926330 Free PMC article. - Phenotype and Function of Myeloid-Derived Suppressor Cells Induced by Porphyromonas gingivalis Infection.
Su L, Xu Q, Zhang P, Michalek SM, Katz J. Su L, et al. Infect Immun. 2017 Jul 19;85(8):e00213-17. doi: 10.1128/IAI.00213-17. Print 2017 Aug. Infect Immun. 2017. PMID: 28533469 Free PMC article. - The role of dietary fatty acid intake in inflammatory gene expression: a critical review.
Rocha DM, Bressan J, Hermsdorff HH. Rocha DM, et al. Sao Paulo Med J. 2017 Mar-Apr;135(2):157-168. doi: 10.1590/1516-3180.2016.008607072016. Epub 2017 Jan 5. Sao Paulo Med J. 2017. PMID: 28076613 Free PMC article. Review.
References
- J Exp Med. 1986 May 1;163(5):1267-80 - PubMed
- Immunology. 1985 Nov;56(3):441-9 - PubMed
- J Biol Chem. 1987 Mar 5;262(7):2941-4 - PubMed
- J Immunol. 1987 Apr 15;138(8):2535-40 - PubMed
- J Rheumatol. 1987 Feb;14(1):33-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources